Article in Substance use & misuse, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
1 citing paper in PubMed, 5 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
5 authors at 1 institution in 1 country.
Stevie C BritchCenter on Drug and Alcohol Research, University of Kentucky, Lexington, KY, USA.ORCID 0000-0002-8361-7799
Sharon L WalshCenter on Drug and Alcohol Research, University of Kentucky, Lexington, KY, USA.
Rachel Vickers-SmithCenter on Drug and Alcohol Research, University of Kentucky, Lexington, KY, USA.
Shanna BabalonisCenter on Drug and Alcohol Research, University of Kentucky, Lexington, KY, USA.
Svetla SlavovaDepartment of Biostatistics, University of Kentucky, Lexington, KY, USA.
University of Kentucky · US
Funding
Research Training in Drug Abuse BehaviorT32DA035200 · NIDA · UNIVERSITY OF KENTUCKY · PI CRAIG R RUSH, William Walton Stoops · 2013 to 2026
$4.4M
Cannabis Modulation of Outcomes Related to Opioid Use Disorder: Opioid Withdrawal, Opioid Abuse Potential and Opioid SafetyR01DA054347 · NIDA · UNIVERSITY OF KENTUCKY · PI Shanna Babalonis · 2022 to 2026
$2.8M
Evaluation of Marijuana and Opioid Drug Interactions: Assessment of the Safety Profile, Abuse-Related Pharmacodynamic Effects and Models of Drug IntakeR01DA045700 · NIDA · UNIVERSITY OF KENTUCKY · PI BABALONIS, SHANNA · 2018 to 2021
$2.3M
Evaluating Recreational and Medical Marijuana Strains for Impairing Effects on Simulated Driving PerformanceR21DA045101 · NIDA · UNIVERSITY OF KENTUCKY · PI BABALONIS, SHANNA · 2018 to 2019
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Cannabinoid Poisoning-Related Emergency Department Visits and Inpatient Hospitalizations in Kentucky, 2017 to 2019. · full record | OpenQuestion